/

Company exports

Pro company pages include CSV downloads for statements, ratios, chart data, and transcript indexes.

CSV downloads

Materials·4005.T

Sumitomo Chemical Company, Limited

JPX · JP

Chemical group with semiconductor photoresists, process chemicals, and electronic materials.

AI relevance

Patterning and specialty materials support wafer fabrication.

Materials Masks / Litho

Price

$542.80

Change

-25.30 (-4.45%)

Market cap

$896.4B

52w range

$335–$625

Exchange

JPX

Country

Jason's Chips

Subscribe or sign in with your Substack email for charts, exports, estimates, transcripts, filings, earnings, and news.

Subscribe to Jason's Chips Sign in

Price chart

4005.T market performance

Daily close for Sumitomo Chemical Company, Limited

Latest close: $542.8
Range move: +$199.7 (+58.2%)
Range high: $623.6
Range low: $336.8
Latest volume: 22.8M
Source: FMP EOD

Downloads

Exports

Download statements, ratios, chart data, and transcript indexes.

CSV

Income statement

12 annual rows

Revenue, gross profit, R&D, operating income, EBITDA, net income, and EPS.

Annual

Balance sheet

12 annual rows

Cash, receivables, inventory, PP&E, assets, debt, liabilities, and equity.

Annual

Cash flow

12 annual rows

Operating cash flow, capital expenditures, and free cash flow.

Annual

Key metrics

12 annual rows

Enterprise value, valuation multiples, returns, yields, and cash conversion.

Annual

Ratios

12 annual rows

Margins, liquidity ratios, valuation ratios, leverage, and per-share metrics.

Annual

Chart data

1222 rows

Five years of daily close and volume data powering the company chart.

Download

Transcript list

8 rows

Available earnings-call transcript dates by fiscal year and quarter.

Download

Street

Analyst expectations

Consensus target

Target range

-- - --

Rating mix

Next FY revenue

$2.47T

2027-03-31

Next FY EPS

$50.22

$43.87 - $60.91

Annual estimates

Period	Revenue avg	Revenue range	EPS avg	EPS range	EBITDA avg	EBIT avg	Net income avg	SG&A avg	Analysts
2027-03-31	$2.47T	$2.32T - $2.72T	$50.22	$43.87 - $60.91	$161.41B	$21.00B	$87.68B	$442.32B	9 rev / 9 EPS
2028-03-31	$2.54T	$2.29T - $2.80T	$52.56	$32.18 - $74.62	$166.22B	$21.63B	$92.37B	$455.51B	8 rev / 8 EPS
2029-03-31	$2.63T	$2.62T - $2.65T	$63.83	$46.04 - $103.41	$171.98B	$22.38B	$100.26B	$471.30B	6 rev / 6 EPS
2030-03-31	$2.71T	$2.49T - $2.99T	$56.20	$50.31 - $63.61	$177.30B	$23.07B	$92.21B	$485.87B	3 rev / 2 EPS
2031-03-31	$2.71T	$2.49T - $2.98T	$50.30	$45.03 - $56.93	$176.98B	$23.03B	$82.53B	$484.98B	2 rev / 3 EPS

Quarterly estimates

Period	Revenue avg	Revenue range	EPS avg	EPS range	EBITDA avg	EBIT avg	Net income avg	SG&A avg	Analysts
2026-06-30	$588.65B	$556.00B - $619.11B	$14.43	$12.61 - $15.94	$38.46B	$5.00B	$23.50B	$105.40B	3 rev / 1 EPS
2026-09-30	$634.10B	$547.12B - $702.92B	$20.79	$18.17 - $22.97	$41.43B	$5.39B	$33.86B	$113.54B	3 rev / 1 EPS
2026-12-31	$667.75B	$602.95B - $721.59B	$15.35	$13.41 - $16.96	$43.63B	$5.68B	$24.99B	$119.57B	2 rev / 1 EPS
2027-03-31	$733.95B	$662.73B - $793.13B	$1.28	$1.12 - $1.42	$47.96B	$6.24B	$2.09B	$131.42B	1 rev / 1 EPS
2027-06-30	$609.50B	$550.35B - $658.65B	$12.47	$10.90 - $13.78	$39.83B	$5.18B	$20.31B	$109.14B	2 rev / 1 EPS
2027-09-30	$669.40B	$604.44B - $723.38B	$12.60	$11.01 - $13.92	$43.74B	$5.69B	$20.51B	$119.86B	2 rev / 1 EPS
2027-12-31	$664.30B	$599.84B - $717.87B	$15.20	$13.28 - $16.79	$43.41B	$5.65B	$24.75B	$118.95B	1 rev / 1 EPS
2028-03-31	$842.60B	$760.83B - $910.54B	$17.68	$15.45 - $19.54	$55.06B	$7.16B	$28.79B	$150.87B	1 rev / 1 EPS

Price target history

No price target summary on file.

Latest grade actions

No grade actions on file.

Historical rating snapshots

Date	Strong buy	Buy	Hold
2026-06-01	1	4	6
2026-05-01	1	3	6
2026-04-01	1	3	6
2026-03-01	1	4	6
2026-02-01	1	5	5
2026-01-01	1	5	5
2025-12-01	1	5	5
2025-11-01	1	5	6

FinancialsFY 2026

Financials

Revenue

$2.33T

Gross margin

28.7%

Operating income

$102.76B

Free cash flow

$113.19B

Cash + ST investments

$208.59B

Net debt

$942.87B

ROE

6.0%

ROIC

3.9%

EV / sales

0.8x

EV / EBITDA

5.9x

R&D / revenue

0.0%

Current ratio

1.5x

Income statement annual

Period	Revenue	Gross profit	Gross margin	R&D	Operating income	EBITDA	Net income	EPS
FY 2026	$2.33T	$668.27B	28.7%	$0	$102.76B	$300.91B	$60.95B	$37.16
FY 2025	$2.61T	$675.79B	25.9%	$141.73B	$144.09B	$228.50B	$38.59B	$23.59
FY 2024	$2.45T	$445.78B	18.2%	$179.06B	-$113.87B	-$275.08B	-$311.84B	$-190.69
FY 2023	$2.90T	$762.12B	26.3%	$191.18B	$47.25B	$192.28B	$6.99B	$4.27
FY 2022	$2.77T	$820.50B	29.7%	$171.92B	$188.46B	$430.86B	$162.13B	$99.16
FY 2021	$2.29T	$741.04B	32.4%	$178.65B	$159.96B	$295.98B	$46.04B	$28.16
FY 2020	$2.23T	$685.11B	30.8%	$174.32B	$120.43B	$252.17B	$30.93B	$18.91
FY 2019	$2.32T	$724.35B	31.2%	$163.47B	$163.79B	$276.28B	$117.99B	$72.17
FY 2018	$2.19T	$734.55B	33.5%	$165.34B	$195.89B	$303.00B	$133.77B	$81.81
FY 2017	$1.94T	$618.69B	31.9%	$158.00B	$139.39B	$249.69B	$76.54B	$46.81
FY 2016	$2.10T	$686.22B	32.6%	$155.77B	$164.45B	$281.05B	$81.45B	$49.84
FY 2015	$2.38T	$636.69B	26.8%	$147.92B	$127.35B	$246.52B	$52.19B	$31.93

Cash flow annual

Period	Operating cash flow	Capex	Free cash flow
FY 2026	$234.76B	$121.57B	$113.19B
FY 2025	$233.03B	$130.47B	$102.56B
FY 2024	-$51.32B	$152.87B	-$204.19B
FY 2023	$111.62B	$143.58B	-$31.96B
FY 2022	$171.72B	$107.47B	$64.25B
FY 2021	$374.46B	$120.81B	$253.65B
FY 2020	$106.01B	$120.45B	-$14.44B
FY 2019	$208.14B	$174.82B	$33.33B
FY 2018	$293.25B	$149.21B	$144.04B
FY 2017	$185.78B	$137.99B	$47.79B
FY 2016	$261.17B	$89.77B	$171.41B
FY 2015	$260.85B	$93.07B	$167.79B

Balance sheet annual

Period	Cash + ST inv.	Receivables	Inventory	PP&E	Assets	Debt	Net debt	Liabilities	Equity
FY 2026	$208.59B	$608.67B	$595.47B	$770.69B	$3.41T	$1.15T	$942.87B	$2.17T	$1.01T
FY 2025	$209.84B	$593.84B	$625.24B	$759.27B	$3.44T	$1.37T	$1.16T	$2.37T	$900.79B
FY 2024	$217.45B	$620.02B	$709.64B	$796.53B	$3.93T	$1.66T	$1.44T	$2.77T	$965.75B
FY 2023	$305.84B	$603.16B	$744.47B	$829.36B	$4.17T	$1.55T	$1.25T	$2.68T	$1.17T
FY 2022	$365.43B	$720.42B	$651.36B	$823.02B	$4.31T	$1.44T	$1.07T	$2.61T	$1.22T
FY 2021	$360.92B	$652.62B	$511.53B	$793.50B	$3.99T	$1.42T	$1.06T	$2.51T	$1.02T
FY 2020	$180.65B	$549.99B	$492.39B	$778.42B	$3.65T	$1.36T	$1.18T	$2.26T	$923.99B
FY 2019	$201.68B	$549.99B	$489.27B	$735.92B	$3.17T	$846.45B	$644.77B	$1.82T	$998.70B
FY 2018	$231.93B	$530.57B	$446.80B	$675.75B	$3.07T	$850.46B	$618.53B	$1.82T	$927.14B
FY 2017	$195.06B	$453.22B	$409.38B	$644.06B	$2.88T	$892.94B	$699.64B	$1.76T	$812.61B
FY 2016	$217.59B	$413.19B	$402.25B	$642.17B	$2.66T	$831.50B	$694.95B	$1.57T	$766.87B
FY 2015	$223.56B	$454.14B	$439.88B	$694.43B	$2.88T	$980.17B	$867.91B	$1.76T	$791.32B

Annual ratios and key metrics

Period	Gross margin	Op margin	Net margin	Current	Quick	ROE	ROIC	EV / sales	EV / EBITDA	FCF yield	R&D / rev.	Cash cycle
FY 2026	28.7%	4.4%	2.6%	1.5x	0.9x	6.0%	3.9%	0.8x	5.9x	13.8%	0.0%	124d
FY 2025	25.9%	5.5%	1.5%	1.5x	0.9x	4.3%	4.0%	0.7x	7.7x	17.3%	5.4%	109d
FY 2024	18.2%	-4.7%	-12.7%	1.2x	0.7x	-32.3%	-3.7%	0.8x	-7.2x	-37.2%	7.3%	123d
FY 2023	26.3%	1.6%	0.2%	1.4x	0.8x	0.6%	-291.9%	0.7x	10.3x	-4.4%	6.6%	115d
FY 2022	29.7%	6.8%	5.9%	1.5x	1.0x	13.3%	4.1%	0.7x	4.6x	7.0%	6.2%	114d
FY 2021	32.4%	7.0%	2.0%	1.5x	1.0x	4.5%	2.5%	0.9x	6.7x	27.1%	7.8%	101d
FY 2020	30.8%	5.4%	1.4%	1.1x	0.7x	3.3%	1.7%	0.8x	6.8x	-2.8%	7.8%	104d
FY 2019	31.2%	7.1%	5.1%	1.3x	0.8x	11.8%	5.5%	0.7x	5.5x	3.9%	7.1%	88d
FY 2018	33.5%	8.9%	6.1%	1.2x	0.8x	14.4%	6.2%	0.7x	5.4x	14.2%	7.5%	78d
FY 2017	31.9%	7.2%	3.9%	1.2x	0.8x	9.4%	5.6%	0.9x	6.9x	4.7%	8.1%	83d
FY 2016	32.6%	7.8%	3.9%	1.5x	1.0x	10.6%	5.6%	0.7x	5.4x	20.6%	7.4%	123d
FY 2015	26.8%	5.4%	2.2%	1.4x	0.9x	6.6%	3.4%	0.8x	7.6x	16.6%	6.2%	108d

Annual growth

Period	Revenue	Gross profit	R&D	Op income	Net income	EPS	FCF	Capex	Cash + ST inv.	Inventory	Assets	Debt
FY 2026	-10.7%	-1.1%	-100.0%	-28.7%	+57.9%	+57.5%	+10.4%	+6.8%	-0.6%	-4.8%	-1.0%	-15.9%
FY 2025	+6.5%	+51.6%	-20.8%	+226.5%	+112.4%	+112.4%	+150.2%	+14.7%	-3.5%	-11.9%	-12.6%	-17.3%
FY 2024	-15.5%	-41.5%	-6.3%	-341.0%	-4563.1%	-4565.8%	-538.9%	-6.5%	-28.9%	-4.7%	-5.5%	+6.6%
FY 2023	+4.7%	-7.1%	+11.2%	-74.9%	-95.7%	-95.7%	-149.7%	-33.6%	-16.3%	+14.3%	-3.3%	+8.1%
FY 2022	+20.9%	+10.7%	-3.8%	+17.8%	+252.1%	+252.1%	-74.7%	+11.0%	+1.2%	+27.3%	+8.0%	+1.2%
FY 2021	+2.7%	+8.2%	+2.5%	+32.8%	+48.9%	+48.9%	+1857.0%	-0.3%	+99.8%	+3.9%	+9.2%	+4.2%
FY 2020	-4.0%	-5.4%	+6.6%	-26.5%	-73.8%	-73.8%	-143.3%	+31.1%	-10.4%	+0.6%	+15.2%	+60.9%
FY 2019	+5.8%	-1.4%	-1.1%	-16.4%	-11.8%	-11.8%	-76.9%	-17.2%	-13.0%	+9.5%	+3.4%	-0.5%
FY 2018	+13.0%	+18.7%	+4.6%	+40.5%	+74.8%	+74.8%	+201.4%	-8.1%	+18.9%	+9.1%	+6.6%	-4.8%
FY 2017	-7.7%	-9.8%	+1.4%	-15.2%	-6.0%	-6.1%	-72.1%	-53.7%	-10.4%	+1.8%	+8.1%	+7.4%
FY 2016	-11.6%	+7.8%	+5.3%	+29.1%	+56.1%	+56.1%	+2.2%	+3.5%	-2.7%	-8.6%	-7.6%	-15.2%
FY 2015	+5.9%	+11.7%	+13.5%	+26.3%	+41.1%	+41.2%	+314.8%	+39.5%	+35.7%	+2.4%	+3.3%	-8.8%

Segments

Revenue Mix

Revenue segmentation data unavailable.

Transcripts8 on file

Transcripts

Events

Next earnings

2026-07-31EPS est $14.43

Analyst expectations

Consensus target

Target range

-- - --

Rating mix

Next FY revenue

$2.47T

2027-03-31

Next FY EPS

$50.22

$43.87 - $60.91

Annual estimates

Period	Revenue avg	Revenue range	EPS avg	EPS range	EBITDA avg	EBIT avg	Net income avg	SG&A avg	Analysts
2027-03-31	$2.47T	$2.32T - $2.72T	$50.22	$43.87 - $60.91	$161.41B	$21.00B	$87.68B	$442.32B	9 rev / 9 EPS
2028-03-31	$2.54T	$2.29T - $2.80T	$52.56	$32.18 - $74.62	$166.22B	$21.63B	$92.37B	$455.51B	8 rev / 8 EPS
2029-03-31	$2.63T	$2.62T - $2.65T	$63.83	$46.04 - $103.41	$171.98B	$22.38B	$100.26B	$471.30B	6 rev / 6 EPS
2030-03-31	$2.71T	$2.49T - $2.99T	$56.20	$50.31 - $63.61	$177.30B	$23.07B	$92.21B	$485.87B	3 rev / 2 EPS
2031-03-31	$2.71T	$2.49T - $2.98T	$50.30	$45.03 - $56.93	$176.98B	$23.03B	$82.53B	$484.98B	2 rev / 3 EPS

Quarterly estimates

Period	Revenue avg	Revenue range	EPS avg	EPS range	EBITDA avg	EBIT avg	Net income avg	SG&A avg	Analysts
2026-06-30	$588.65B	$556.00B - $619.11B	$14.43	$12.61 - $15.94	$38.46B	$5.00B	$23.50B	$105.40B	3 rev / 1 EPS
2026-09-30	$634.10B	$547.12B - $702.92B	$20.79	$18.17 - $22.97	$41.43B	$5.39B	$33.86B	$113.54B	3 rev / 1 EPS
2026-12-31	$667.75B	$602.95B - $721.59B	$15.35	$13.41 - $16.96	$43.63B	$5.68B	$24.99B	$119.57B	2 rev / 1 EPS
2027-03-31	$733.95B	$662.73B - $793.13B	$1.28	$1.12 - $1.42	$47.96B	$6.24B	$2.09B	$131.42B	1 rev / 1 EPS
2027-06-30	$609.50B	$550.35B - $658.65B	$12.47	$10.90 - $13.78	$39.83B	$5.18B	$20.31B	$109.14B	2 rev / 1 EPS
2027-09-30	$669.40B	$604.44B - $723.38B	$12.60	$11.01 - $13.92	$43.74B	$5.69B	$20.51B	$119.86B	2 rev / 1 EPS
2027-12-31	$664.30B	$599.84B - $717.87B	$15.20	$13.28 - $16.79	$43.41B	$5.65B	$24.75B	$118.95B	1 rev / 1 EPS
2028-03-31	$842.60B	$760.83B - $910.54B	$17.68	$15.45 - $19.54	$55.06B	$7.16B	$28.79B	$150.87B	1 rev / 1 EPS

Price target history

No price target summary on file.

Latest grade actions

No grade actions on file.

Historical rating snapshots

Date	Strong buy	Buy	Hold
2026-06-01	1	4	6
2026-05-01	1	3	6
2026-04-01	1	3	6
2026-03-01	1	4	6
2026-02-01	1	5	5
2026-01-01	1	5	5
2025-12-01	1	5	5
2025-11-01	1	5	6

Financials

Revenue

$2.33T

Gross margin

28.7%

Operating income

$102.76B

Free cash flow

$113.19B

Cash + ST investments

$208.59B

Net debt

$942.87B

ROE

6.0%

ROIC

3.9%

EV / sales

0.8x

EV / EBITDA

5.9x

R&D / revenue

0.0%

Current ratio

1.5x

Income statement annual

Period	Revenue	Gross profit	Gross margin	R&D	Operating income	EBITDA	Net income	EPS
FY 2026	$2.33T	$668.27B	28.7%	$0	$102.76B	$300.91B	$60.95B	$37.16
FY 2025	$2.61T	$675.79B	25.9%	$141.73B	$144.09B	$228.50B	$38.59B	$23.59
FY 2024	$2.45T	$445.78B	18.2%	$179.06B	-$113.87B	-$275.08B	-$311.84B	$-190.69
FY 2023	$2.90T	$762.12B	26.3%	$191.18B	$47.25B	$192.28B	$6.99B	$4.27
FY 2022	$2.77T	$820.50B	29.7%	$171.92B	$188.46B	$430.86B	$162.13B	$99.16
FY 2021	$2.29T	$741.04B	32.4%	$178.65B	$159.96B	$295.98B	$46.04B	$28.16
FY 2020	$2.23T	$685.11B	30.8%	$174.32B	$120.43B	$252.17B	$30.93B	$18.91
FY 2019	$2.32T	$724.35B	31.2%	$163.47B	$163.79B	$276.28B	$117.99B	$72.17
FY 2018	$2.19T	$734.55B	33.5%	$165.34B	$195.89B	$303.00B	$133.77B	$81.81
FY 2017	$1.94T	$618.69B	31.9%	$158.00B	$139.39B	$249.69B	$76.54B	$46.81
FY 2016	$2.10T	$686.22B	32.6%	$155.77B	$164.45B	$281.05B	$81.45B	$49.84
FY 2015	$2.38T	$636.69B	26.8%	$147.92B	$127.35B	$246.52B	$52.19B	$31.93

Cash flow annual

Period	Operating cash flow	Capex	Free cash flow
FY 2026	$234.76B	$121.57B	$113.19B
FY 2025	$233.03B	$130.47B	$102.56B
FY 2024	-$51.32B	$152.87B	-$204.19B
FY 2023	$111.62B	$143.58B	-$31.96B
FY 2022	$171.72B	$107.47B	$64.25B
FY 2021	$374.46B	$120.81B	$253.65B
FY 2020	$106.01B	$120.45B	-$14.44B
FY 2019	$208.14B	$174.82B	$33.33B
FY 2018	$293.25B	$149.21B	$144.04B
FY 2017	$185.78B	$137.99B	$47.79B
FY 2016	$261.17B	$89.77B	$171.41B
FY 2015	$260.85B	$93.07B	$167.79B

Balance sheet annual

Period	Cash + ST inv.	Receivables	Inventory	PP&E	Assets	Debt	Net debt	Liabilities	Equity
FY 2026	$208.59B	$608.67B	$595.47B	$770.69B	$3.41T	$1.15T	$942.87B	$2.17T	$1.01T
FY 2025	$209.84B	$593.84B	$625.24B	$759.27B	$3.44T	$1.37T	$1.16T	$2.37T	$900.79B
FY 2024	$217.45B	$620.02B	$709.64B	$796.53B	$3.93T	$1.66T	$1.44T	$2.77T	$965.75B
FY 2023	$305.84B	$603.16B	$744.47B	$829.36B	$4.17T	$1.55T	$1.25T	$2.68T	$1.17T
FY 2022	$365.43B	$720.42B	$651.36B	$823.02B	$4.31T	$1.44T	$1.07T	$2.61T	$1.22T
FY 2021	$360.92B	$652.62B	$511.53B	$793.50B	$3.99T	$1.42T	$1.06T	$2.51T	$1.02T
FY 2020	$180.65B	$549.99B	$492.39B	$778.42B	$3.65T	$1.36T	$1.18T	$2.26T	$923.99B
FY 2019	$201.68B	$549.99B	$489.27B	$735.92B	$3.17T	$846.45B	$644.77B	$1.82T	$998.70B
FY 2018	$231.93B	$530.57B	$446.80B	$675.75B	$3.07T	$850.46B	$618.53B	$1.82T	$927.14B
FY 2017	$195.06B	$453.22B	$409.38B	$644.06B	$2.88T	$892.94B	$699.64B	$1.76T	$812.61B
FY 2016	$217.59B	$413.19B	$402.25B	$642.17B	$2.66T	$831.50B	$694.95B	$1.57T	$766.87B
FY 2015	$223.56B	$454.14B	$439.88B	$694.43B	$2.88T	$980.17B	$867.91B	$1.76T	$791.32B

Annual ratios and key metrics

Period	Gross margin	Op margin	Net margin	Current	Quick	ROE	ROIC	EV / sales	EV / EBITDA	FCF yield	R&D / rev.	Cash cycle
FY 2026	28.7%	4.4%	2.6%	1.5x	0.9x	6.0%	3.9%	0.8x	5.9x	13.8%	0.0%	124d
FY 2025	25.9%	5.5%	1.5%	1.5x	0.9x	4.3%	4.0%	0.7x	7.7x	17.3%	5.4%	109d
FY 2024	18.2%	-4.7%	-12.7%	1.2x	0.7x	-32.3%	-3.7%	0.8x	-7.2x	-37.2%	7.3%	123d
FY 2023	26.3%	1.6%	0.2%	1.4x	0.8x	0.6%	-291.9%	0.7x	10.3x	-4.4%	6.6%	115d
FY 2022	29.7%	6.8%	5.9%	1.5x	1.0x	13.3%	4.1%	0.7x	4.6x	7.0%	6.2%	114d
FY 2021	32.4%	7.0%	2.0%	1.5x	1.0x	4.5%	2.5%	0.9x	6.7x	27.1%	7.8%	101d
FY 2020	30.8%	5.4%	1.4%	1.1x	0.7x	3.3%	1.7%	0.8x	6.8x	-2.8%	7.8%	104d
FY 2019	31.2%	7.1%	5.1%	1.3x	0.8x	11.8%	5.5%	0.7x	5.5x	3.9%	7.1%	88d
FY 2018	33.5%	8.9%	6.1%	1.2x	0.8x	14.4%	6.2%	0.7x	5.4x	14.2%	7.5%	78d
FY 2017	31.9%	7.2%	3.9%	1.2x	0.8x	9.4%	5.6%	0.9x	6.9x	4.7%	8.1%	83d
FY 2016	32.6%	7.8%	3.9%	1.5x	1.0x	10.6%	5.6%	0.7x	5.4x	20.6%	7.4%	123d
FY 2015	26.8%	5.4%	2.2%	1.4x	0.9x	6.6%	3.4%	0.8x	7.6x	16.6%	6.2%	108d

Annual growth

Period	Revenue	Gross profit	R&D	Op income	Net income	EPS	FCF	Capex	Cash + ST inv.	Inventory	Assets	Debt
FY 2026	-10.7%	-1.1%	-100.0%	-28.7%	+57.9%	+57.5%	+10.4%	+6.8%	-0.6%	-4.8%	-1.0%	-15.9%
FY 2025	+6.5%	+51.6%	-20.8%	+226.5%	+112.4%	+112.4%	+150.2%	+14.7%	-3.5%	-11.9%	-12.6%	-17.3%
FY 2024	-15.5%	-41.5%	-6.3%	-341.0%	-4563.1%	-4565.8%	-538.9%	-6.5%	-28.9%	-4.7%	-5.5%	+6.6%
FY 2023	+4.7%	-7.1%	+11.2%	-74.9%	-95.7%	-95.7%	-149.7%	-33.6%	-16.3%	+14.3%	-3.3%	+8.1%
FY 2022	+20.9%	+10.7%	-3.8%	+17.8%	+252.1%	+252.1%	-74.7%	+11.0%	+1.2%	+27.3%	+8.0%	+1.2%
FY 2021	+2.7%	+8.2%	+2.5%	+32.8%	+48.9%	+48.9%	+1857.0%	-0.3%	+99.8%	+3.9%	+9.2%	+4.2%
FY 2020	-4.0%	-5.4%	+6.6%	-26.5%	-73.8%	-73.8%	-143.3%	+31.1%	-10.4%	+0.6%	+15.2%	+60.9%
FY 2019	+5.8%	-1.4%	-1.1%	-16.4%	-11.8%	-11.8%	-76.9%	-17.2%	-13.0%	+9.5%	+3.4%	-0.5%
FY 2018	+13.0%	+18.7%	+4.6%	+40.5%	+74.8%	+74.8%	+201.4%	-8.1%	+18.9%	+9.1%	+6.6%	-4.8%
FY 2017	-7.7%	-9.8%	+1.4%	-15.2%	-6.0%	-6.1%	-72.1%	-53.7%	-10.4%	+1.8%	+8.1%	+7.4%
FY 2016	-11.6%	+7.8%	+5.3%	+29.1%	+56.1%	+56.1%	+2.2%	+3.5%	-2.7%	-8.6%	-7.6%	-15.2%
FY 2015	+5.9%	+11.7%	+13.5%	+26.3%	+41.1%	+41.2%	+314.8%	+39.5%	+35.7%	+2.4%	+3.3%	-8.8%